Skip to main content
Clinical Trials/ACTRN12615001001583
ACTRN12615001001583
Active, not recruiting
Not Applicable

Evaluating the usability, acceptability and impact of a gamification/mindfulness e-tool for young people

Young and Well Cooperative Research Centre0 sites270 target enrollmentSeptember 25, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
The experience of stress & distress in young people.
Sponsor
Young and Well Cooperative Research Centre
Enrollment
270
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 25, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Young and Well Cooperative Research Centre

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 16 \- 25 years
  • 2\. Experience mild to moderate levels of distress
  • 3\. Have regular access to a computer or smartphone
  • 4\. Have not extensively engaged in Mindfulness activities in the recent past

Exclusion Criteria

  • 1\. Do not experience mild level of distress
  • 2\. Do not have regular access to a computer or smartphone
  • 3\. Have engaged in regular or recent mindfulness practice

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Development of a website for family/friends of adults with depressioCarer mental healthDepressionMental Health - Studies of normal psychology, cognitive function and behaviourMental Health - Depression
ACTRN12624000864527Deakin University30
Completed
Not Applicable
The evaluation of usability, acceptability and immediate outcomes from the use of smartphone application for neck pain self-management in smartphone users with neck paieck painNeck painSmartphone applicationNeck pain self managementSelf managementAlternative therapy
TCTR20190124003Graduate School, Khon Kaen University100
Active, not recruiting
Phase 1
To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapychildren aged 6 years or more receiving growth hormone therapy for the following approved indications (according to Norditropine SPC)-GHD-Turner Syndrome-small for gestational age-chronic renal insufficiency
EUCTR2009-017387-16-FRovo Nordisk Pharmaceutique S.A.S
Not yet recruiting
Not Applicable
Evaluation of the acceptability, safety and effectiveness of thermal ablation in the prevention of cervical neoplasia in ZimbabweCancer
PACTR202103552074172International Agency for Research on Cancer184
Recruiting
Not Applicable
Pilot trial of the Health4Life apppoor dietinsufficient physical activityalcohol usetobacco usepoor sleepexcessive recreational screen timePublic Health - Health promotion/education
ACTRN12622001087741HMRC CTC75